Stereotactic ablative radiotherapy for inoperable T1-2N0M0 small-cell lung cancer

被引：4
|
作者：
Tang, Hui [1 ]
Liu, Wei [1 ]
Huang, Kaiming [2 ]
机构：
[1] Wenzhou Med Univ, Dept Intervent, Lishui Peoples Hosp, Affiliated Hosp 6, Lishui, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 6, Lishui Peoples Hosp, Dept Thyroid Gland & Breast Surg, Lishui 323000, Peoples R China
来源：
THORACIC CANCER | 2022年 / 13卷 / 07期
关键词：
D O I：
10.1111/1759-7714.14355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1100 / 1101
页数：2
相关论文
共 50 条
  • [1] Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis
    Safavi, Amir H.
    Mak, David Y.
    Boldt, R. Gabriel
    Chen, Hanbo
    Louie, Alexander, V
    [J]. LUNG CANCER, 2021, 160 : 179 - 186
  • [2] Stereotactic Ablative Radiotherapy in T1-2N0M0 Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Safavi, A. H.
    Mak, D.
    Boldt, G.
    Chen, H.
    Louie, A. V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E106 - E107
  • [3] STEREOTACTIC ABLATIVE RADIOTHERAPY IN T1-2N0M0 SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Safavi, Amir H.
    Mak, David Y. P.
    Boldt, R. Gabriel
    Chen, Hanbo
    Louie, Alexander V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S85 - S85
  • [4] Stereotactic ablative radiotherapy ( SABR) for non-small cell lung cancer (NSCLC): analysis of T3N0M0 patients
    Pickles, R.
    Atherton, P.
    Turnbull, H.
    Burns, A.
    Iqbal, M. S.
    [J]. LUNG CANCER, 2020, 139 : S31 - S31
  • [5] Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer
    Djarv, Emma
    Nyman, Jan
    Baumann, Pia
    Ekberg, Lars
    Hoyer, Morten
    Lax, Ingmar
    Lewensohn, Rolf
    Levin, Nina
    Lund, Jo-Asmund
    Morhed, Elisabeth
    Ericsson, Susanne Rehn
    Traberg, Anders
    Wittgren, Lena
    Johansson, Karl-Axel
    [J]. ACTA ONCOLOGICA, 2006, 45 (07) : 973 - 977
  • [6] Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
    Li, Ming
    Yang, Xiaodong
    Chen, Yuhan
    Yang, Xinyu
    Dai, Xiyu
    Sun, Fenghao
    Zhang, Li
    Zhan, Cheng
    Feng, Mingxiang
    Wang, Qun
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 2885 - 2892
  • [7] The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis
    Ning, Jing
    Ge, Tao
    Zhu, Shuncang
    Han, Yingli
    Ruan, Suhong
    Ma, Yuchen
    Liu, Rentao
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
    Nestle, Ursula
    Belderbos, Jose
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 623 - 626
  • [9] Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
    Woodford, Katrina
    Senthi, Sashendra
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 619 - 622
  • [10] Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Sanuki, Naoko
    Nishimura, Shuichi
    Takagawa, Yoshiaki
    Enomoto, Tatsuji
    Saeki, Noriyuki
    Yashiro, Kae
    Mizuno, Tomikazu
    Aoki, Yousuke
    Oku, Yohei
    Yokosuka, Tetsuya
    Shigematsu, Naoyuki
    [J]. JOURNAL OF RADIATION RESEARCH, 2016, 57 (03) : 265 - 272
12345